Search Result "Antiparkinsonian Agents"
The Use of Antiparkinsonian Agents in the Management of Drug-Induced Extrapyramidal Symptoms
Journal: Current Pharmaceutical Design
Volume: 10 Issue: 1 Year: 2004 Page: 2239-2248
Author(s): K. Burgyone, K. Aduri, J. Ananth, S. Parameswaran
Parkinson Disease and Antiparkinsonian Drugs
Ebook: Medicinal Chemistry for Pharmacy Students
Volume: 2 Year: 2020
Author(s): Ashok E. Philip,George DeMaagd,M. O. Faruk Khan
Doi: 10.2174/9789811454073120020010
Antiparkinsonian Potential of Natural Products: Molecular Docking,Prediction of Pharmacokinetic and Toxicological Properties
Journal: Current Physical Chemistry
Volume: 13 Issue: 1 Year: 2023 Page: 75-89
Author(s): Henrique B. Lima,Jaderson V. Ferreira,Mariela L. Nery,Gisele A. Chaves,Anderson L. P. da Costa,Lucilene R. de Souza,Bianca L. Marino,Maiara F.B. Brito,Hueldem R.C. Teixeira,Carlos H.T.P. Silva,Carlton A. Taft,Lorane I.S. Hage-Melim
3-Methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol: the Importance of Functional Groups for Antiparkinsonian Activity
Journal: Medicinal Chemistry
Volume: 9 Issue: 5 Year: 2013 Page: 731-739
Author(s): Oleg V. Ardashov,Alla V. Pavlova,Dina V. Korchagina,Konstantin P. Volcho,Tat’ yana G. Tolstikova,Nariman F. Salakhutdinov
Medicinal Plants and Natural Compounds as Antiparkinsonian Agents
Ebook: Neurodegenerative Diseases: Multifactorial Degenerative Processes, Biomarkers and Therapeutic Approaches (First Edition)
Volume: 1 Year: 2022
Author(s): Saumitra Sen Singh,Aaina Singh Rathore,Priyanka Kumari Keshri,Surya Pratap Singh
Doi: 10.2174/9789815040913122010014
Piribedil: Antiparkinsonian Properties and Potential Clinical Utility in Dopaminergic Disorders
Journal: Current Drug Therapy
Volume: 6 Issue: 1 Year: 2011 Page: 17-34
Author(s): Aravind Mittur
A New Series of 1,3-Dimethylxanthine Based Adenosine A2A Receptor Antagonists as a Non-Dopaminergic Treatment of Parkinsonâs Disease
Journal: Current Drug Discovery Technologies
Volume: 18 Issue: 5 Year: 2021 Page: 3-13
Author(s): Suman Rohilla,Ranju Bansal,Puneet Chauhan,Sonja Kachler,Karl-Norbert Klotz
The Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP): A New Rodent Model to Test Palliative and Neuroprotective Agents for Parkinsons disease
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 5 Year: 2011 Page: 489-507
Author(s): Rui D. S. Prediger, Aderbal S. Aguiar, Eduardo L. G. Moreira, Filipe C. Matheus, Adalberto A. Castro, Roger Walz, Andreza F. De Bem, Alexandra Latini, Carla I. Tasca, Marcelo Farina, Rita Raisman-Vozari
Different Generations of Type-B Monoamine Oxidase Inhibitors in Parkinsonâs Disease: From Bench to Bedside
Journal: Current Neuropharmacology
Volume: 17 Issue: 9 Year: 2019 Page: 861-873
Author(s): Marika Alborghetti,Ferdinando Nicoletti
Substance Abuse and Movement Disorders: Complex Interactions and Comorbidities
Journal: Current Drug Abuse Reviews
Volume: 5 Issue: 3 Year: 2012 Page: 243-253
Author(s): Andres Deik,Rachel Saunders-Pullman,Marta San Luciano